A Companion Sample Collection Protocol to Support the Discovery of Breast Cancer Aberrations With Treatment of CDK4/6 Therapy/LEE011/Ribociclib

NCT03050398 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped GCP issues.

Conditions

Breast Cancer

Interventions

DRUG: Ribociclib
DRUG: letrozole

Sponsor

Novartis Pharmaceuticals